[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 371
Citations 0
Clinical Trials Update
October 27, 2015

Benznidazole Does Not Affect Chagas Cardiomyopathy

JAMA. 2015;314(16):1684. doi:10.1001/jama.2015.12704

Although trypanocidal therapy with benznidazole effectively cures the acute phase of Chagas disease, it did not significantly alter cardiac deterioration in Chagas cardiomyopathy in a trial conducted in Argentina, Bolivia, Brazil, Columbia, and El Salvador. Chagas disease ranks as the third most common parasitic disease globally, with approximately 25% of infected patients developing Chagas cardiomyopathy (Morillo CA et al. N Engl J Med. doi:10.1056/NEJMoa1507574 [published online September 1, 2015]).

First Page Preview View Large
First page PDF preview
First page PDF preview
×